ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 61

$447K Total Retail Price of All Prescriptions

Rank: 18 out of 61

125 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 125 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 125 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 4,934 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

65 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
DIVALPROEX SODIUM 356 159 1 64
LISINOPRIL 281 193 2 2
SIMVASTATIN 263 150 3 1
CITALOPRAM HBR 251 188 4 18
LEVOTHYROXINE SODIUM 215 122 5 3
METOPROLOL TARTRATE 197 130 6 8
OMEPRAZOLE 181 84 7 5
LANTUS 177 111 8 39
FUROSEMIDE 173 140 9 4
WARFARIN SODIUM 169 111 10 11
TRIHEXYPHENIDYL HCL 160 74 R 11 142
QUETIAPINE FUMARATE 154 95 12 56
LITHIUM CARBONATE 152 82 13 149
FLUPHENAZINE HCL 144 106 14 152
HALOPERIDOL 129 66 15 109
RISPERIDONE 127 81 16 65
METFORMIN HCL 126 76 17 9
AMLODIPINE BESYLATE 118 68 18 6
LOXAPINE 110 68 19 171
TAMSULOSIN HCL 108 90 20 35
OLANZAPINE 106 44 21 108
MIRTAZAPINE 105 65 22 43
HYDROCODONE-ACETAMINOPHEN 101 51 S3 23 7
OLANZAPINE ODT 100 52 24 177
SEROQUEL 93 55 25 119
NOVOLOG 83 58 26 94
GENERLAC 82 48 27 155
ENULOSE 80 47 28 188
CARBAMAZEPINE 76 69 29 162
OXYBUTYNIN CHLORIDE ER 71 45 30 63
CARBIDOPA-LEVODOPA 70 60 31 109
TRAZODONE HCL 69 45 32 34
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 48 32 73
PROMETHAZINE HCL 67 18 R 34 124
FAMOTIDINE 65 34 35 84
SUCRALFATE 65 40 35 128
CHLORPROMAZINE HCL 63 20 37 204
ATORVASTATIN CALCIUM 62 35 38 13
PHENYTOIN SODIUM EXTENDED 61 36 39 105
OXYCODONE-ACETAMINOPHEN 61 0 S2 39 21
SELENIUM SULFIDE 54 21 41 222
HYDROCHLOROTHIAZIDE 51 31 42 10
DIVALPROEX SODIUM ER 51 34 42 118
MEDROXYPROGESTERONE ACETATE 50 40 44 239
CARVEDILOL 50 33 44 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.